Tridentate Facial Ligation of [Ni(PyA-R)3]- and [Ni(MeImA)3]-
Fourier transform IR spectra of the samples in KBr disks were
recorded with a Perkin-Elmer 2000 FT-IR instrument. Electronic
absorption spectra in solution were measured with a Perkin-Elmer
Lambda 19 spectrophotometer. Magnetic susceptibilities of pow-
dered samples were recorded with a SQUID magnetometer in the
temperature range 2-290 K with an applied field of 1 T.
Experimental susceptibility data were corrected for the underlying
diamagnetism using Pascal’s constants and for the temperature-
independent paramagnetism contributions. Cyclic voltammetry (CV)
and coulometric measurements were performed using EG&G
equipment (potentiostat/galvanostat model 273A). Mass spectra
were recorded with either a Finnigan MAT 8200 (electron ioniza-
tion, EI-MS) or a MAT 95 (electrospray ionization, ESI-MS)
instrument. A Bruker DRX 400 instrument was used for NMR
spectroscopy. X-band electron paramagnetic resonance (EPR)
spectra were recorded with a Bruker ELEXSYS E500 spectrometer
equipped with a helium-flow cryostat (Oxford Instruments ESR
910).
Preparations. The macrocycle 1,4,7-trimethyl-1,4,7-triazacy-
clononane (C9H21N3dL) was prepared as described previously.20
2-Acetylpyridinealdoxime [HPyA-Me]. To an ice-cold solution
of Na2CO3 (1.06 g, 10 mmol) and NH2OH‚HCl (1.4 g, 20 mmol)
in water (20 mL) was added 2-acetylpyridine (2.4 g, 20 mmol),
and the resulting suspension was stirred at ∼4 °C for 2 h. The
suspension was kept in a refrigerator overnight and then filtered to
procure the solid material, which was washed with a cold methanol/
water (1:3) solvent mixture. Yield: 2.4 g (∼88%). Purity checked
by gas chromatography (GC): ∼98%. EI-MS: m/z 136 [M]+.
1-Methyl-2-imidazolealdoxime [MeImAH]. A protocol very
similar to that for HPyA-Me was used. Yield: 69%. Mp: 168-
169 °C. Purity checked by GC: ∼99%. EI-MS: m/z 125 [M]+.
[NiII(PyA-H)3FeIII(PyA-H)3NiII]ClO4 (1). To a light-green solu-
tion of NiCl2‚6H2O (0.47 g, 2 mmol) in distilled methanol (50 mL)
were added successively with stirring solid pyridine-2-aldoxime
(HPyA-H; 0.72 g, 6 mmol) and Fe(ClO4)2‚6H2O (0.37 g, 1 mmol).
To the resulting solution was added 10 mL of [Bu4N][OCH3] (20%
in CH3OH), which upon stirring yielded a deep-brown solution.
After 24 h, the precipitated brown microcrystalline substance was
filtered, washed thoroughly with methanol, and air-dried. Yield:
0.51 g (∼51%). X-ray-quality black-brown crystals were obtained
by diffusion of methanol to a dimethylformamide solution of 1.
Anal. Calcd for C36H30ClFeNi2N12O10: C, 43.27; H, 3.03; N, 16.82;
Ni, 11.75; Fe, 5.59. Found: C, 43.2; H, 3.0; N, 16.8; Ni, 11.9; Fe,
5.7. IR (KBr, cm-1): 1663m, 1602s, 1541m, 1473s, 1431m, 1341m,
1220m, 1121s, 1080s, 1013m, 889m, 778m, 686s, 640s, 623m,
522m. ESI-MS (positive mode) in CH3OH/H2O: m/z (%) 899.0
(100%) [M - ClO4]+, 776.9 (20%) [M - ClO4 - C6H5N2O]+.
[LMnIII(PyA-H)3NiII](ClO4)2 (2). Mn(ClO4)2‚6H2O (0.36 g, 1
mmol) was added to a solution of 1,4,7-trimethyl-1,4,7-triazacy-
clononane (0.34 g, 2 mmol) in 25 mL of methanol under vigorous
stirring, resulting in a brown solution. Another red-brown solution
was produced by stirring NiCl2‚6H2O (0.24 g, 1 mmol) and
pyridinealdoxime (HPyA-H; 0.36 g, 3 mmol) in 25 mL of methanol.
The above-mentioned two solutions were mixed together and stirred
at room temperature for 15 min, to which sodium perchlorate
monohydrate (0.14 g) dissolved in methanol (5 mL) was added.
The solution yielded after 24 h red-brown needle-shaped crystals,
which were filtered and dried in air. Yield: 0.38 g (∼45%).
Parallelogram-shaped deep-brown crystals were grown from an
acetonitrile solution for the X-ray structural characterization. Anal.
Calcd for C27H36Cl2MnNiN9O11 (847.18): C, 38.28; H, 4.28; N,
14.88; Mn, 6.48; Ni, 6.93. Found: C, 38.1; H, 4.3; N, 15.0; Mn,
6.6; Ni, 6.7. IR (KBr, cm-1): 1604m, 1551w, 1537w, 1476m,
1465m, 1384w, 1345w, 1302w, 1218w, 1121s, 1091vs, 1054s,
1010m, 783m, 749w, 742w, 688w, 624m, 520w. UV-vis in CH3-
CN [λmax, nm (ꢀ, M-1 cm-1)]: 248 (29 150) 310 (2959), 498sh
(∼1578), 906 (34.7). ESI-MS (positive mode) in CH2Cl2: m/z (%)
764.1 (∼2) (MClO4+), 323.7 (∼1) (M2+).
[LNiII(PyA-H)3NiII]ClO4 (3a). To a solution of NiCl2‚6H2O
(0.48 g, 2 mmol) in 25 mL of distilled methanol was added with
stirring 1,4,7-trimethyl-1,4,7-triazacyclononane (0.17 g, 1 mmol).
To the resulting greenish-blue solution were added pyridine-2-
aldoxime (HPyA-H; 0.36 g, 3 mmol) and triethylamine (1 mL).
The solution was stirred for 0.5 h to yield a dark-brown solution,
which was kept open overnight for evaporation. The solid was taken
up in acetonitrile, and the mixture was filtered to remove any solid
particles. The acetonitrile solution yielded after 1 week deep-brown
crystals, which were collected by filtration. Yield: 0.25 g (33%).
Deep-brown crystals were grown from an acetonitrile solution for
the X-ray structural characterization. Anal. Calcd for C27H36-
ClNi2N9O7: C, 43.15; H, 4.83; N, 16.78; Ni, 15.62. Found: C,
43.1; H, 4.8; N, 16.6; Ni, 15.6. IR (KBr, cm-1): 1601s, 1530m,
1474s, 1159m, 1138s, 1120s, 1096s, 1014m, 989m, 779m, 680m,
624m. UV-vis in CH2Cl2 [λmax, nm (ꢀ, M-1 cm-1)]: 276 (38 965),
336 (27 280), 498 (569), 827 (31), 949 (41∧). ESI-MS (positive
mode) in CH3OH: m/z (%) 650.3 (100%) [M - ClO4]+.
[LNiII(PyA-Me)3NiII]ClO4 (3b) and [LNiII(PyA-Ph)3NiII]ClO4
(3c). Complexes 3b and 3c were prepared by the same protocol as
that for 3a using HPyA-Me for 3b and HPyA-Ph for 3c. Deep-
brown crystals were grown from a methanol solution for the X-ray
structural characterization. Complex 3b. Yield: 0.30 g (37%). Anal.
Calcd for C30H42ClN9Ni2O7: C, 45.41; H, 5.34; N, 15.89; Ni, 14.79.
Found: C, 45.6; H, 5.4; N, 15.9; Ni, 14.8. IR (KBr, cm-1): 3007,
2961, 2893, 2856, 2816m, 1594s, 1571m, 1524s, 1463s, 1203s,
1188s, 1180s, 1107s, 1086s, 1045m, 1018m, 990m, 780s, 750m,
700m, 638m, 622m. UV-vis in CH2Cl2 [λmax, nm (ꢀ, M-1 cm-1)]:
285 (31 500), 341 (22 660), 483 (540). ESI-MS (positive mode) in
CH3OH: m/z (%) 692.3 (100%) [M - ClO4]+. Complex 3c.
Yield: 0.69 g (70%). Anal. Calcd for C45H48ClN9Ni2O7: C, 55.17;
H, 4.94; N, 12.87; Ni, 11.98. Found: C, 55.2; H, 5.0; N, 12.8; Ni,
12.0. IR (KBr, cm-1): 2886m, 2816m, 1590s, 1568m, 1456s, 1440s,
1263m, 1218s, 1142s, 1123s, 1107s, 1060s, 1017s, 975s, 792m,
780s, 745m, 708s, 638m, 622m. UV-vis in CH2Cl2 [λmax, nm (ꢀ,
M-1 cm-1)]: 291 (31 500), 349 (19 300), 510 (580), 833 (35), 942
(40). ESI-MS (positive mode) in CH3OH: m/z (%) 880.3 (100%)
[M - ClO4]+.
[LNiII(MeImA)3NiII]ClO4 (4). The same protocol as that for 3a
was used for preparing complex 4 by replacing pyridine-2-aldoxime
with 1-methylimidazole-2-aldoxime. Deep-brown crystals were
obtained from a methanol solution for the X-ray structure deter-
mination. Yield: 0.59 g (77%). Anal. Calcd for C24H39ClN12-
Ni2O7: C, 37.91; H, 5.17; N, 22.10; Ni, 15.43. Found: C, 38.0; H,
5.2; N, 22.0; Ni, 15.1. IR (KBr, cm-1): 3552m, 3408m, 3237m,
3113m, 2890m, 2854m, 2813m, 1557s, 1458s, 1293m, 1282m,
1220s, 1137s, 1106s, 1057s, 1013s, 865m, 776m, 746m, 717m,
672m, 624m. UV-vis in CH2Cl2 [λmax, nm (ꢀ, M-1 cm-1)]: 442
(340), 648 (30), 820 (30), 955 (44). ESI-MS (positive mode) in
CH3OH: m/z (%) 659.3 (100%) [M - ClO4]+.
[LZnII(PyA)3NiII]ClO4 (5). Zinc chloride (0.136 g, 1 mmol) was
added to a solution of 1,4,7-trimethyl-1,4,7-triazacyclononane (0.17
g, 1 mmol) in 25 mL of methanol under vigorous stirring, resulting
in a pale-yellow solution. Another orange-red solution was produced
by stirring Ni(ClO4)2‚6H2O (0.37 g, 1 mmol), pyridine-2-aldoxime
(20) Wieghardt, K.; Chaudhuri, P.; Nuber, B.; Weiss, J. Inorg. Chem. 1982,
21, 3086.
Inorganic Chemistry, Vol. 46, No. 21, 2007 9005